Searching across hundreds of databases

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Single low-dose lipopolysaccharide preconditioning: neuroprotective against axonal injury and modulates glial cells.

RC Turner | ZJ Naser | BP Lucke-Wold | AF Logsdon | RL Vangilder | RR Matsumoto | JD Huber | CL Rosen
Neuroimmunology and neuroinflammation | 2017 Jan

Over 7 million traumatic brain injuries (TBI) are reported each year in the United States. However, treatments and neuroprotection following TBI are limited because secondary injury cascades are poorly understood. Lipopolysaccharide (LPS) administration before controlled cortical impact can contribute to neuroprotection. However, the underlying mechanisms and whether LPS preconditioning confers neuroprotection against closed-head injuries remains unclear.

Pubmed ID: 28164149

TBI Model

  • Other
  • Impact acceleration injury
  • Animal Information

  • Species: rat
  • Strain: Sprague-Dawley
  • Age (weeks): 13 - 17
  • Weight (grams): No weight reported
  • Assessments

    Fluoro-Jade B staining (FJB), Histology, Locomotor behavior, Immunohistochemistry (IHC)

    TBI model parameters

  • Impact Depth (mm): No information available
  • Impact Duration (ms): No information available
  • Impact Velocity (m/s): No information available
  • Impactor Tip: No information available
  • Device Name

    No information available

    Associated Datasets

    No information available

    Associated Protocols

    No information available